CE Marking: Yes
Profhilo
IBSA Sinovial® HL 64 1x 2.0 ml | Osteoarthritis therapy
Article: Sinovial® HL 64
Manufacturer: IBSA Pharmaceutical
Concentration: Hybrid 3.2% - 32mg (H-HA) + 32mg (L-HA)/2ml
Package content: 1 prefilled syringe à 2.0 ml
Needle/Cannulas: 1 x 21G ½''
Indication: Osteoarthritis therapy
Choose options
Article: Sinovial® HL 64
Manufacturer: IBSA Pharmaceutical
Concentration: Hybrid 3.2% - 32mg (H-HA) + 32mg (L-HA)/2ml
Package content: 1 prefilled syringe à 2.0 ml
Needle/Cannulas: 1 x 21G ½''
Indication: Osteoarthritis therapy
Article: Sinovial® HL 64
Manufacturer: IBSA Pharmaceutical
Concentration: Hybrid 3.2% - 32mg (H-HA) + 32mg (L-HA)/2ml
Package content: 1 prefilled syringe à 2.0 ml
Needle/Cannulas: 1 x 21G ½''
Indication: Osteoarthritis therapy
IBSA Sinovial® | Osteoarthritis Therapy
IBSA Sinovial is a high-quality medical device for intra-articular treatment of osteoarthritic joints. It contains sodium hyaluronate, a natural component of synovial fluid that ensures optimal joint lubrication, shock absorption, and mobility.
SINOVIAL® HL 64 combines high-molecular and low-molecular-weight hyaluronic acid in a buffered saline solution. The hyaluronic acid is produced biotechnologically by fermentation and is not chemically modified, ensuring excellent tolerability. A patented technology enables interaction between different hyaluronic acid chains, giving the product unique viscoelastic properties at high concentration.
Thanks to its increased resistance to enzymatic degradation, SINOVIAL® HL 64 is particularly suitable for intra-articular use. The product supports the restoration of natural synovial fluid, relieves joint pain, and improves mobility.
